These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1368883)

  • 1. Large-scale processing & high-throughput perfusion chromatography.
    Fulton SP; Shahidi AJ; Gordon NF; Afeyan NB
    Biotechnology (N Y); 1992 Jun; 10(6):635-9. PubMed ID: 1368883
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrophobic interaction chromatography of proteins.
    Wu SL; Karger BL
    Methods Enzymol; 1996; 270():27-47. PubMed ID: 8803963
    [No Abstract]   [Full Text] [Related]  

  • 3. Large-scale processing of macromolecules.
    Fulton SP
    Curr Opin Biotechnol; 1994 Feb; 5(2):201-5. PubMed ID: 7764801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very large scale monoclonal antibody purification: the case for conventional unit operations.
    Kelley B
    Biotechnol Prog; 2007; 23(5):995-1008. PubMed ID: 17887772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregates in monoclonal antibody manufacturing processes.
    Vázquez-Rey M; Lang DA
    Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and production of therapeutic grade proteins.
    Garg VK; Costello MA; Czuba BA
    Bioprocess Technol; 1991; 12():29-54. PubMed ID: 1367502
    [No Abstract]   [Full Text] [Related]  

  • 7. Recovery and purification process development for monoclonal antibody production.
    Liu HF; Ma J; Winter C; Bayer R
    MAbs; 2010; 2(5):480-99. PubMed ID: 20647768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process-scale purification from cell culture supernatants: monoclonal antibodies.
    Ostlund C; Borwell P; Malm B
    Dev Biol Stand; 1987; 66():367-75. PubMed ID: 3108053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoaffinity purification of tissue plasminogen activator from serum-supplemented conditioned media using monoclonal antibody.
    Reagan ME; Robb M; Bornstein I; Niday EG
    Thromb Res; 1985 Oct; 40(1):1-9. PubMed ID: 3937281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manufacture of pharmaceutical proteins from hybridomas and other cell substrates.
    Tolbert WR; Rupp RG
    Dev Biol Stand; 1989; 70():49-56. PubMed ID: 2503410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in chromatographic purification of biopharmaceuticals.
    Rathore AS; Kumar D; Kateja N
    Biotechnol Lett; 2018 Jun; 40(6):895-905. PubMed ID: 29700726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large scale, rapid purification of recombinant tissue-type plasminogen activator.
    Dodd I; Jalalpour S; Southwick W; Newsome P; Browne MJ; Robinson JH
    FEBS Lett; 1986 Dec; 209(1):13-7. PubMed ID: 3100325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control of rDNA-derived human tissue-type plasminogen activator.
    Jones AJ; Garnick RL
    Bioprocess Technol; 1990; 10():543-66. PubMed ID: 1367501
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic behaviour of a deglycosylated t-PA mutant lacking the growth factor domain.
    Mitchell DL; Dodd I; Esmail AF; Browne MJ
    Biochem Soc Trans; 1993 Nov; 21(4):330S. PubMed ID: 8131916
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of high-capacity cation exchange chromatography for direct capture of monoclonal antibodies from high-titer cell culture processes.
    Tao Y; Ibraheem A; Conley L; Cecchini D; Ghose S
    Biotechnol Bioeng; 2014 Jul; 111(7):1354-64. PubMed ID: 24420791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale process purification of clinical product from animal cell cultures.
    Prior CP
    Biotechnology; 1991; 17():445-78. PubMed ID: 2049550
    [No Abstract]   [Full Text] [Related]  

  • 17. Downstream processing: key to slashing production costs 100 fold.
    Spalding BJ
    Biotechnology (N Y); 1991 Mar; 9(3):229-3, 232, 235. PubMed ID: 1367296
    [No Abstract]   [Full Text] [Related]  

  • 18. Chromatographic purification of recombinant human erythropoietin.
    Adamíková J; Antošová M; Polakovič M
    Biotechnol Lett; 2019 May; 41(4-5):483-493. PubMed ID: 30810853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturability.
    Conley GP; Viswanathan M; Hou Y; Rank DL; Lindberg AP; Cramer SM; Ladner RC; Nixon AE; Chen J
    Biotechnol Bioeng; 2011 Nov; 108(11):2634-44. PubMed ID: 21618474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization studies of human tissue-type plasminogen activator produced by recombinant DNA technology.
    Vehar GA; Spellman MW; Keyt BA; Ferguson CK; Keck RG; Chloupek RC; Harris R; Bennett WF; Builder SE; Hancock WS
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 1():551-62. PubMed ID: 2953546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.